ADH and Acetaldehyde Scavenger Composition for Faster Ethanol Clearance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing solutions fail to simultaneously address the rapid reduction of blood ethanol concentration and mitigate acetaldehyde toxicity during alcohol metabolism, which can lead to tissue damage, oxidative stress, and other adverse effects.

Innovation Solution

A pharmaceutical composition combining alcohol dehydrogenase (ADH) with acetaldehyde scavengers, such as thiol-containing compounds or agents that sequester acetaldehyde, to accelerate ethanol metabolism and neutralize acetaldehyde, leveraging Le Chatelier's principle to drive the reaction forward.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If alcohol dehydrogenase activity is enhanced to accelerate ethanol clearance, then blood ethanol concentration is reduced more rapidly, but acetaldehyde concentration increases and exacerbates toxicity

Engineering Contradiction:
Improveethanol clearance rateVSAvoidacetaldehyde toxicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and removes the harmful acetaldehyde intermediate from the metabolic pathway by introducing exogenous acetaldehyde scavengers (such as cysteamine, mercapturic acid, or their derivatives) that selectively bind and eliminate acetaldehyde from the system, preventing its accumulation and toxic effects while allowing ADH to continue converting ethanol to acetaldehyde

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces acetaldehyde scavengers as intermediary substances that mediate between the ethanol-to-acetaldehyde conversion and the subsequent metabolic steps. These scavengers act as temporary carriers that bind acetaldehyde, prevent its harmful effects, and can be subsequently processed by the body's natural pathways

Inventive Principle:
Principle #24Intermediary (Mediator)

2Object-affected harmful factors

If acetaldehyde scavengers are used to reduce acetaldehyde concentration, then acetaldehyde toxicity is mitigated, but ethanol metabolism may be inhibited

Engineering Contradiction:
Improveacetaldehyde toxicityVSAvoidethanol metabolism rate
Core Design Contradiction:
Object-affected harmful factorsVSProductivity

Solution Approach 1:

The patent optimizes the parameters of acetaldehyde scavengers, including their chemical structure, binding affinity, and pharmacokinetic properties, to achieve the ideal balance between acetaldehyde removal efficiency and ethanol metabolism preservation. Specific modifications to scavenger molecules allow selective binding to acetaldehyde while maintaining compatibility with the ADH-catalyzed ethanol conversion

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If both alcohol dehydrogenase and acetaldehyde scavengers are administered together, then both ethanol clearance and acetaldehyde toxicity mitigation are achieved, but the system complexity increases

Engineering Contradiction:
Improveacetaldehyde toxicityVSAvoidtreatment system complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The patent combines ADH enzyme therapy with acetaldehyde scavenger administration into a unified treatment protocol, where both components work synergistically to address ethanol intoxication and acetaldehyde toxicity simultaneously, creating a comprehensive solution that manages both aspects of alcohol metabolism

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The combination effectively reduces blood ethanol concentration and mitigates acetaldehyde toxicity, enhancing ethanol metabolism and protecting against alcohol-induced damage by maintaining enzymatic activity and reducing oxidative stress.

Implementation Method 1

Alcohol dehydrogenases (ADHes) are the primary enzymes for catalyzing the conversion of ethanol (EtOH) to acetaldehyde (AcH)

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 2

catalyzing the conversion of ethanol (EtOH) to acetaldehyde (AcH)

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 3

an acetaldehyde (AcH) scavenger... thiol-containing compound or an agent that sequesters AcH

Methodology Applied
Scientific EffectChemical binding: Chemical Bonding

Data Source

PatentUS12527847B1Compositions and methods for reducing blood ethanol concentration through alcohol dehydrogenase and acetaldehyde scavengers
Publication Date: 2026.01.20 GOA THERAPEUTICS CORP
  • US12527847B1 patent drawing

AI summary

The present disclosure relates to compositions and methods for reducing blood ethanol concentration through a dual-action mechanism involving alcohol dehydrogenase (ADH) and acetaldehyde (AcH) scavengers. The present disclosure provides a formulation that accelerates ethanol (EtOH) metabolism via ADH and rapidly eliminates AcH using scavengers, thereby driving the reaction equilibrium forward to enhance EtOH clearance.